
Organization · Private Equity
GL Capital Group
GL Capital Group is a private equity firm based in China, specializing in value investments within the healthcare sector, particularly in pharmaceuticals and medical enterprises. Founded in 2010, it focuses on buyouts and significant minority opportunities.
Overview
What GL Capital Group does
What GL Capital Group is
GL Capital Group is a private equity firm based in China, specializing in value investments within the healthcare sector, particularly in pharmaceuticals and medical enterprises. Founded in 2010, it focuses on buyouts and significant minority opportunities.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2010
- Approximate age
- About 16 years
- Structured capabilities
- Funder
- Last reviewed
- March 3, 2026
Official channels
Find GL Capital Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
GL Capital Group as a funder
Investment thesis
GL Capital specializes in investments within the healthcare industry, targeting companies with sustainable competitive advantages. The firm aims to collaborate with visionary management teams and pursues both mergers and acquisitions as well as growth equity opportunities.
Focus narrative
GL Capital specializes in investments within the healthcare industry, including pharmaceuticals, medical services, IVD (in vitro diagnostics), and CXO (contract research organization) sectors. The firm targets companies with sustainable competitive advantages and aims to collaborate with visionary management teams. Their investment strategy encompasses both mergers and acquisitions as well as growth equity opportunities.
Focus and fit
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 99
Portfolio context
GL Capital has invested in 99 companies across the healthcare value chain. Notable portfolio companies include MaiXin Biotechnology, SaiSheng Pharmaceuticals, XiHua Testing, Kanglong Chemical, YouDe Medical, and XuDong HaiPu.
Connected ecosystem
Continue from GL Capital Group
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about GL Capital Group
Upseed classifies GL Capital Group under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.